Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 959 products on this category.

Product data	Purity	Price range	Estimated delivery
Nintedanib Impurity 95 REF: 4Z-N-066108	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 87 REF: 4Z-N-066100	- - -	To inquire	Tue 10 Dec 24
Gimeracil Impurity 23 REF: 4Z-G-047028CAS: 63910-63-4	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 46 REF: 4Z-O-032051	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 78 REF: 4Z-N-066089CAS: 100-23-2	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 9 REF: 4Z-C-121012CAS: 868540-22-1	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 4 REF: 4Z-E-068015	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 27 REF: 4Z-O-032029	- - -	To inquire	Tue 10 Dec 24
Fulvestrant Impurity 16 REF: 4Z-F-3124	- - -	To inquire	Tue 10 Dec 24
(E/Z)-4,4'-Dihydroxy-N-Desmethyl Tamoxifen-d3 REF: 4Z-T-0135CAS: 1246832-93-8	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 99 REF: 4Z-N-066113	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 32 REF: 4Z-C-121035	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 26 REF: 4Z-L-124031	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 3 REF: 4Z-O-032005CAS: 61260-15-9	- - -	To inquire	Tue 10 Dec 24
Tamoxifen Impurity 2 REF: 4Z-T-0122CAS: 123091-15-6	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 31 REF: 4Z-L-124037	- - -	To inquire	Tue 10 Dec 24
Bestatin Impurity 7 REF: 4Z-B-119010	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 27 REF: 4Z-C-121030	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 72 REF: 4Z-C-121075CAS: 771-61-9	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 36 REF: 4Z-C-121039CAS: 1140908-89-9	- - -	To inquire	Tue 10 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Nintedanib Impurity 95

Ref: 4Z-N-066108

Nintedanib Impurity 87

Ref: 4Z-N-066100

Gimeracil Impurity 23

Ref: 4Z-G-047028

Olaparib Impurity 46

Ref: 4Z-O-032051

Nintedanib Impurity 78

Ref: 4Z-N-066089

Carfilzomib Impurity 9

Ref: 4Z-C-121012

Enzalutamide Impurity 4

Ref: 4Z-E-068015

Olaparib Impurity 27

Ref: 4Z-O-032029

Fulvestrant Impurity 16

Ref: 4Z-F-3124

(E/Z)-4,4'-Dihydroxy-N-Desmethyl Tamoxifen-d3

Ref: 4Z-T-0135

Nintedanib Impurity 99

Ref: 4Z-N-066113

Carfilzomib Impurity 32

Ref: 4Z-C-121035

Lenvatinib Impurity 26

Ref: 4Z-L-124031

Olaparib Impurity 3

Ref: 4Z-O-032005

Tamoxifen Impurity 2

Ref: 4Z-T-0122

Lenvatinib Impurity 31

Ref: 4Z-L-124037

Bestatin Impurity 7

Ref: 4Z-B-119010

Carfilzomib Impurity 27

Ref: 4Z-C-121030

Carfilzomib Impurity 72

Ref: 4Z-C-121075

Carfilzomib Impurity 36

Ref: 4Z-C-121039